David Cullinane
Question:821. Deputy David Cullinane asked the Minister for Health to outline the breakdown of actual spending within the medicines budget from 2020 to 2024, distinguishing between off-patent medicines, including generic and biosimilar medicines and new or originator medicines; and to provide an estimate of the total savings generated for the State by the off-patent medicines industry during the same period, specifically those resulting from the launch of generic or biosimilar medicines following the expiration of originator patents. [6305/25]
View answer